Skip to main content

Coenzyme Q Biosynthesis Disorders

  • Chapter
  • First Online:
Mitochondrial Diseases

Abstract

Coenzyme Q (CoQ) is a lipidic molecule that transfers electrons between complexes I and II to complex III in the mitochondrial respiratory chain. It is also essential for processes mediated by other mitochondrial dehydrogenases, such as those involved in pyrimidine nucleotides biosynthesis, beta-oxidation and sulfide biosynthesis. A nuclear-encoded multiprotein complex at the inner mitochondrial membrane drives CoQ biosynthesis, which requires at least 13 proteins, leastways in yeasts. Mutations in the genes (COQ genes) coding for these proteins cause a decrease of CoQ biosynthesis rate leading to primary CoQ deficiency, a very heterogeneous group of mitochondrial diseases affecting different tissues and organs, and showing variable severity and age of onset. In general, this primary condition shows a good response to the supplementation with high doses of CoQ, but early diagnosis is compulsory to limit tissue damage. However, sometimes effectiveness is reduced, possibly due to its low bioavailability and, probably, difficulties crossing the blood-brain barrier. Secondary CoQ deficiency is a more common condition, in which defects of diverse mitochondrial processes induce an adaptive CoQ decrease. Secondary deficiency can be caused by oxidative phosphorylation (OXPHOS) defects, such as complex III dysfunction or mitochondrial DNA (mtDNA) depletion, or even non-OXPHOS mitochondrial defects. Here, we review the current knowledge of CoQ biosynthesis pathway, the genetic defects leading to primary deficiency and those conditions in which mitochondrial defects cause secondary deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Download references

Acknowledgements

Our research was funded by the Instituto de Salud Carlos III PI20/00541 and Junta de Andalucía P18-RT-4572 grants, the FEDER Funding Program from the European Union, and the Italian Ministry of Health GR-2016-02362779 grant. It was also partially supported by the institutional grant Unidad de Excelencia María de Maeztu (MDM-2016-0687 to the Department of Gene regulation and morphogenesis of Centro Andaluz de Biología del Desarrollo).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Plácido Navas .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Brea-Calvo, G., Alcázar-Fabra, M., Trevisson, E., Navas, P. (2021). Coenzyme Q Biosynthesis Disorders. In: Navas, P., Salviati, L. (eds) Mitochondrial Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-70147-5_6

Download citation

Publish with us

Policies and ethics